Browse Drug Recalls

21 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 21 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 21 FDA drug recalls.

Clear
DateProductReasonClassFirm
Feb 9, 2023 aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Pac... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Allergy ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg, 180-count cart... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Non-Drowsy Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 150-co... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count ... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Picnic, Fexofenadine Hydrochloride Tablets, 180 mg, Antihistamine, 90-count c... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons,... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Fexofenadine Hydrochloride Tablets, 180 mg, 100-count cartons, Distributed by... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons,... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-c... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Feb 9, 2023 allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-... Failed Impurities/Degradation Specifications Class II L. Perrigo Company
Nov 6, 2018 Antacid Tablets, Calcium Carbonate chewable tablets, 750mg, 60-count bottle, ... Presence of foreign substance: Product found to contain metal particles. Class II L. Perrigo Company
May 11, 2018 Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 4580... Defective delivery system Class II L. Perrigo Company
Nov 8, 2017 Maximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. ... Microbial Contamination of Non-Sterile Products Class II L. Perrigo Company
Jun 5, 2017 Walgreens Daytime and Nighttime Cold & Flu, packaged in combo pack of two pla... Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the... Class III L. Perrigo Company
Jun 1, 2017 Option 2, Levonorgestrel Tablet, 1.5 mg, Emergency Contraceptive, 1 Tablet pe... Defective Container: Carton is missing the tablet blister strip and tablet. Class II L. Perrigo Company
Feb 13, 2017 Salicylic Acid Shampoo, 6%, 177 mL bottle, Rx only, Manufactured By Perrigo Y... Failed Impurities/Degradation Specifications: The API for these products had an out of specificat... Class III L. Perrigo Company
Feb 13, 2017 Salicylic Acid Cream, 6%, 400g bottle, Rx Only, Manufactured By Perrigo Yeruh... Failed Impurities/Degradation Specifications: The API for these products had an out of specificat... Class III L. Perrigo Company
Dec 28, 2016 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%, 45 g tubes, Rx Only,... Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of... Class II L. Perrigo Company

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.